Sutro Biopharma Stock (NASDAQ: STRO) stock price, news, charts, stock research, profile.
You can purchase shares of Sutro Biopharma (NASDAQ:STRO) through any online brokerage.
Other companies in Sutro Biopharma’s space includes: Zura Bio (NASDAQ:ZURA), Aligos Therapeutics (NASDAQ:ALGS), Adaptimmune Therapeutics (NASDAQ:ADAP), Kyverna Therapeutics (NASDAQ:KYTX) and TScan Therapeutics (NASDAQ:TCRX).
Sutro Biopharma has a consensus price target of $11.22.
The stock price for Sutro Biopharma (NASDAQ: STRO) is $1.88 last updated December 24, 2024 at 4:57 PM EST.
There are no upcoming dividends for Sutro Biopharma.
Sutro Biopharma’s Q4 earnings are confirmed for Monday, March 24, 2025.
There is no upcoming split for Sutro Biopharma.
Sutro Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.